- This event has passed.
Dr. Gül Dölen: The Latest Research on Psychedelics and the Brain
January 10 @ 10:00 am - 11:00 am PST
Free
On Friday, January 10th, at 10 a.m. PT/ 1 p.m. ET, University of California, Berkeley’s Dr. Gül Dölen joins Being Patient Live Talks to discuss her research on psychedelics and the brain, as well as potential applications in brain health research.
Dölen is a Professor and the Renee and Bob Parsons Endowed chair in the Department of Psychology, the Helen Wills Neuroscience Institute, and the Berkeley Center for the Science of Psychedelics at the University of California, Berkeley. She’s also an adjunct professor in Neuroscience and Neurology at the Johns Hopkins University School of Medicine. Dölen is a leading researcher in psychedelic research, focusing on how psychedelic drugs like MDMA, LSD, psilocybin, ketamine, and ibogaine could be used therapeutically.
RSVP to this talk to learn more about her latest research on psychedelics and the brain, and its potential therapeutic applications.
This sounds amazing! Hopefully the medical prescription world is catching up to include psychedelics!
Thank you for being here, Lorraine! Researchers are exploring how psychedelic drugs like psilocybin may hold potential therapeutic effects in treating Alzheimer’s disease. Here’s a great article on psychedelics and Alzheimer’s if you’re interested: https://www.beingpatient.com/could-psychedelics-help-treat-alzheimers/?utm_source=organic&utm_medium=social